Fosun Almond PulseTranslation site

Fosun Apricot Pulse, known as Shanghai Apricot Pulse Information Technology Co., Ltd, is the first independently incubated artificial intelligence enterprise under Fosun Group, focusing onMedical Imagingof artificial intelligence technologies and applications.

Company Background and Profile

• Established: Fosun Apricot Pulse has been growing at a high rate since its inception in 2017.
• Team Size: As of today, the company has a team of about 180 people with strong R&D and technical support capabilities.
• Financing: The company has completed several rounds of financing, including Pre-A round and strategic financing, and has been highly recognized by the capital market. Among them, Fosun Pharmaceuticals, Apricot Discovery Investment, and Yadong Zhijian and other organizations have participated in the company's financing.
• technical strengthFosun Apricot Pulse has deep technical accumulation in the field of medical imaging artificial intelligence, and its R&D capability and technical maturity have reached the international leading level.

Business & Products

• Core businessFosun Apricot Pulse is committed to applying artificial intelligence and other technological technologies to solve industry pain points from medical technology to clinic and provide precision medical solutions.
• Product Matrix: The company has built a multi-product matrix, including artificial intelligence systems such as Apricot Pulse Sharp Shadow. With evidence-based medicine as the cornerstone, Apricot Pulse Sharp Shadow utilizes deep learning, computer vision, hemodynamics and other technological means to assist in medical imaging diagnosis and improve the diagnostic efficiency and accuracy of medical institutions at all levels.
• application scenarioFosun Apricot Pulse's products and services have been widely used in radiology, laboratory, pathology, respiratory, orthopedics, cardiology, neurology and other departments, forming a total solution for multiple diseases from diagnosis to treatment.

Technology Innovation and R&D

• R&D investmentFosun Apricot Pulse, as the spearhead of Fosun's "innovation-driven" strategy and the core platform of the medical artificial intelligence industry, has continuously increased its investment in scientific and technological research and development to promote technological innovation.
• Technical results: To date, the company has accumulated a stockpile of over 40 AI disease models and has won awards in several world-renowned medical imaging competitions.

Markets and Cooperation

• marketplaceFosun Apricot Pulse explores the real needs of medical institutions and grassroots health service scenarios, and actively improves the core scenarios of hierarchical diagnosis and treatment, such as early screening, remote diagnosis and treatment, and precision medicine.
• Cooperating Organizations: The company has reached cooperation with more than 500 medical institutions across the country, forming a wide market coverage and deep industry influence.

future outlook

• The direction of developmentFosun Apricot Pulse will continue to adhere to the concept of "Craftsmanship + Innovation", and continuously increase investment in research and development of science and technology to promote the development and application of artificial intelligence technology in medical imaging.
• social responsibilityThe company is committed to comprehensively solving different clinical pain points and public health problems, through the unique "AI + X" product form, effectively empowering the construction of remote diagnosis and treatment system, and helping China's hierarchical diagnosis and treatment and precision medical solutions to the ground.

In summary, Fosun Apricot Pulse, as a medical imaging artificial intelligence enterprise under Fosun Group, has made remarkable achievements and extensive influence in the field of medical imaging artificial intelligence by virtue of its strong technical strength, rich product matrix and extensive market coverage. In the future, the company will continue to plough into the field of medical imaging artificial intelligence and make greater contributions to the development of China's medical and healthcare industry.